These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1756751)

  • 21. [Neuropsychological investigation in multiple sclerosis].
    Tei H; Soma Y; Maruyama S
    No To Shinkei; 1993 Feb; 45(2):133-7. PubMed ID: 8476663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findings.
    Nocentini U; Rossini PM; Carlesimo GA; Graceffa A; Grasso MG; Lupoi D; Oliveri M; Orlacchio A; Pozzilli C; Rizzato B; Caltagirone C
    Eur Neurol; 2001; 45(1):11-8. PubMed ID: 11150835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
    Uher T; Vaneckova M; Sormani MP; Krasensky J; Sobisek L; Dusankova JB; Seidl Z; Havrdova E; Kalincik T; Benedict RH; Horakova D
    Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study.
    Feinstein A; Kartsounis LD; Miller DH; Youl BD; Ron MA
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):869-76. PubMed ID: 1431949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.
    Tekok-Kilic A; Benedict RH; Zivadinov R
    Expert Rev Neurother; 2006 Mar; 6(3):323-31. PubMed ID: 16533137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis.
    Swirsky-Sacchetti T; Mitchell DR; Seward J; Gonzales C; Lublin F; Knobler R; Field HL
    Neurology; 1992 Jul; 42(7):1291-5. PubMed ID: 1620336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MRI and the diagnosis of multiple sclerosis].
    Lyrer P; Groebke-Lorenz W; Benz UF; Wüthrich R
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1849-53. PubMed ID: 2609142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.
    Sperling RA; Guttmann CR; Hohol MJ; Warfield SK; Jakab M; Parente M; Diamond EL; Daffner KR; Olek MJ; Orav EJ; Kikinis R; Jolesz FA; Weiner HL
    Arch Neurol; 2001 Jan; 58(1):115-21. PubMed ID: 11176944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
    Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationships.
    Maurelli M; Marchioni E; Cerretano R; Bosone D; Bergamaschi R; Citterio A; Martelli A; Sibilla L; Savoldi F
    Acta Neurol Scand; 1992 Aug; 86(2):124-8. PubMed ID: 1414220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
    Nunnari D; De Cola MC; D'Aleo G; Rifici C; Russo M; Sessa E; Bramanti P; Marino S
    Biomed Res Int; 2015; 2015():519785. PubMed ID: 25861633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The structure of mnestic problems in multiple sclerosis: everyday memory performance and neuroradiologic findings].
    Haupts M; Calabrese P; Babinsky R; Gehlen W; Markowitsch HJ
    Schweiz Arch Neurol Psychiatr (1985); 1994; 145(1):14-9. PubMed ID: 7526452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.
    Mesaros S; Rocca MA; Kacar K; Kostic J; Copetti M; Stosic-Opincal T; Preziosa P; Sala S; Riccitelli G; Horsfield MA; Drulovic J; Comi G; Filippi M
    Neurology; 2012 Mar; 78(13):969-75. PubMed ID: 22377806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.
    Comi G; Filippi M; Martinelli V; Sirabian G; Visciani A; Campi A; Mammi S; Rovaris M; Canal N
    J Neurol Sci; 1993 Apr; 115 Suppl():S66-73. PubMed ID: 8340796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher cerebral dysfunction in a case with atypical multiple sclerosis with concentric lesions.
    Morioka C; Nameta K; Komatsu Y; Tsujio T; Kondo H
    Psychiatry Clin Neurosci; 1996 Feb; 50(1):41-4. PubMed ID: 9201770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis.
    Arnett PA; Rao SM; Bernardin L; Grafman J; Yetkin FZ; Lobeck L
    Neurology; 1994 Mar; 44(3 Pt 1):420-5. PubMed ID: 8145908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location.
    Reuter F; Zaaraoui W; Crespy L; Faivre A; Rico A; Malikova I; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Audoin B
    Mult Scler; 2011 Jun; 17(6):755-8. PubMed ID: 21372116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings.
    Leocani L; Locatelli T; Martinelli V; Rovaris M; Falautano M; Filippi M; Magnani G; Comi G
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):192-8. PubMed ID: 10896692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.